1. 1) Koulentaki M, Ioannidou D, Stefanidou M, Maraki S, Drigiannakis I, Dimoulios P, Melono JM, Tosca A, Kouroumalis EA. Dermatological manifestations in primary biliary cirrhosis patients: a case control study. Am. J. Gastroenterol., 101, 541–546 (2006).
2. 2) Rishe E, Azarm A, Bergasa NV. Itch in primary biliary cirrhosis: a patients’ perspective. Acta Derm. Venereol., 88, 34–37 (2008).
3. 3) Hirschfield GM, Beuers U, Corpechot C, Invernizzi P, Jones D, Marzioni M, Schramm C. EASL (European Association for the Study of the Liver) Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J. Hepatol., 67, 145–172 (2017).
4. 4) Schoenfield L, Sjovall J, Perman E. Bile acids in the skin of patients with pruritic hepatobiliary disease. Nature, 213, 93–94 (1967).
5. 5) Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ, 297, 1501–1504 (1988).